We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
-6.85%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$10.1M
(-8.5%)
Cap. Flow
+$2.31M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
38.45%
Holding
73
New
4
Increased
25
Reduced
5
Closed
10
Top Buys
| 1 |
CVS Health
CVS
|
+$1.88M |
| 2 |
ARKO Corp
ARKO
|
+$1.61M |
| 3 |
Baidu
BIDU
|
+$1.51M |
| 4 |
First Financial Corp
THFF
|
+$955K |
| 5 |
Talos Energy
TALO
|
+$935K |
Top Sells
| 1 |
American Superconductor
AMSC
|
+$3.38M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
+$2.96M |
| 3 |
Incyte
INCY
|
+$1.71M |
| 4 |
First Horizon
FHN
|
+$1.54M |
| 5 |
Tejon Ranch
TRC
|
+$693K |
Sector Composition
| 1 | Healthcare | 35.69% |
| 2 | Technology | 11.09% |
| 3 | Materials | 10.64% |
| 4 | Consumer Staples | 8.17% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CVS Health
CVS
$136B
| $1.77M | 1.63% |
+30,000
| New | +$1.88M |
|
27
Evolus
EOLS
$390M
| $1.63M | 1.49% |
150,000
| – | – |
|
28
Sabre
SABR
$712M
| $1.6M | 1.47% |
600,000
+100,000
| +20% | +$280K |
|
|
BRKL
29
DELISTED
Brookline Bancorp
BRKL
| $1.59M | 1.46% |
190,000
+10,000
| +6% | +$87.8K |
|
|
SVC
30
Service Properties Trust
SVC
$1.13B
| $1.54M | 1.41% |
60,000
| – | – |
|
31
Pan American Silver
PAAS
$17.8B
| $1.49M | 1.37% |
75,000
-25,000
| -25% | -$493K |
|
32
Warner Bros
WBD
$67.8B
| $1.49M | 1.37% |
200,000
| – | – |
|
|
33
First Financial Corp
THFF
$923M
| $1.48M | 1.35% |
40,000
+26,000
| +186% | +$955K |
|
34
Pfizer
PFE
$144B
| $1.4M | 1.28% |
50,000
| – | – |
|
35
Jazz Pharmaceuticals
JAZZ
$15.3B
| $1.33M | 1.22% |
12,500
| – | – |
|
36
Xoma
XOMA
| $1.3M | 1.2% |
55,000
| – | – |
|
37
AMCON Distributing
DIT
| $1.15M | 1.06% |
12,300
+300
| +3% | +$31K |
|
38
Newell Brands
NWL
$2.34B
| $1.12M | 1.03% |
175,000
| – | – |
|
39
Heron Therapeutics
HRTX
$87.6M
| $1.05M | 0.96% |
300,000
| – | – |
|
|
RVNC
40
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.03M | 0.94% |
400,000
+150,000
| +60% | +$512K |
|
41
Cohu
COHU
$2.5B
| $993K | 0.91% |
+30,000
| New | +$931K |
|
42
Nektar Therapeutics
NKTR
$2.27B
| $930K | 0.85% |
50,000
-12,656
| -20% | -$267K |
|
43
Atea Pharmaceuticals
AVIR
$387M
| $894K | 0.82% |
270,000
| – | – |
|
44
Hasbro
HAS
$11.6B
| $878K | 0.81% |
+15,000
| New | +$890K |
|
45
Curis
CRIS
$9.32M
| $828K | 0.76% |
6,000
| – | – |
|
46
Kraft Heinz
KHC
$30.7B
| $806K | 0.74% |
+25,000
| New | +$891K |
|
47
Park Hotels & Resorts
PK
$2.96B
| $749K | 0.69% |
50,000
| – | – |
|
48
Acadia Pharmaceuticals
ACAD
$4.47B
| $650K | 0.6% |
40,000
| – | – |
|
49
Coya Therapeutics
COYA
$111M
| $606K | 0.56% |
100,000
| – | – |
|
50
Cytosorbents Corp
CTSO
$23.9M
| $598K | 0.55% |
850,000
+25,000
| +3% | +$21.7K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM